Abstract

BackgroundPridopidine is a selective, potent Sigma-1 Receptor (S1R) agonist in clinical development for HD and ALS. S1R agonists enhance neuroprotective pathways in a biphasic manner, demonstrated in numerous preclinical and...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
MO1019: Sigma-1 Receptor Agonists are Protective in a Rat Model of Kidney Transplantation
Tamas Lakat ... Akos Roland Toth
Nephrology Dialysis Transplantation | VOL. 37
Tamas Lakat, et. al.Tamas Lakat ... Akos Roland Toth
03 May 2022
Bi-phasic dose response in the preclinical and clinical developments of sigma-1 receptor ligands for the treatment of neurodegenerative disorders
Tangui Maurice
Expert opinion on drug discovery | VOL. 16
Tangui MauriceTangui Maurice
27 Oct 2020
F42 Exposure response analysis (PKPD) predicts optimal exposure of pridopidine for clinical efficacy of functional capacity
Michal Geva ... Munish Mehra
Journal of Neurology, Neurosurgery & Psychiatry | VOL. 92
Michal Geva, et. al.Michal Geva ... Munish Mehra
01 Sep 2021
J09 An update on the proof-HD phase 3 trial: pridopidine’s outcome on function in huntington
Ralf Reilmann ... Michael R Hayden
Journal of Neurology, Neurosurgery & Psychiatry | VOL. 93
Ralf Reilmann, et. al.Ralf Reilmann ... Michael R Hayden
01 Sep 2022
View more papers

More From: Journal of Neurology, Neurosurgery & Psychiatry

Paper Title
Journal
Date
Author
Impulse control disorders in Parkinson’s disease: a national Swedish registry study on high-risk treatments and vulnerable patient groups
Mirjam Wolfschlag ... Anders Håkansson
Journal of Neurology, Neurosurgery & Psychiatry | VOL. -
Mirjam Wolfschlag, et. al.Mirjam Wolfschlag ... Anders Håkansson
30 Jul 2024
Cognition in patients with myelin oligodendrocyte glycoprotein antibody-associated disease: a prospective, longitudinal, multicentre study of 113 patients (CogniMOG-Study)
Sarah Passoke ... Martin W Hümmert
Journal of Neurology, Neurosurgery & Psychiatry | VOL. -
Sarah Passoke, et. al.Sarah Passoke ... Martin W Hümmert
30 Jul 2024
White matter abnormalities in healthy E200K carriers may serve as an early biomarker for genetic Creutzfeldt-Jakob disease (gCJD)
Nurit Omer ... Noa Bregman
Journal of Neurology, Neurosurgery & Psychiatry | VOL. -
Nurit Omer, et. al.Nurit Omer ... Noa Bregman
30 Jul 2024
Endovascular therapy versus best medical management in distal medium middle cerebral artery acute ischaemic stroke: a multinational multicentre propensity score-matched study
Hamza Adel Salim ... Adam A Dmytriw
Journal of Neurology, Neurosurgery & Psychiatry | VOL. -
Hamza Adel Salim, et. al.Hamza Adel Salim ... Adam A Dmytriw
23 Jul 2024
View more papers